Egaten

Chemical Nametriclabendazole
Dosage FormTablet (oral; 250 mg)
Drug ClassAnthelmintics
SystemDigestive
CompanyNovartis
Approval Year2019

Indication

  • For the treatment of fascioliasis in patients 6 years of age and older.
Last updated on 4/23/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Egaten (triclabendazole) Prescribing Information. 2019Novartis Pharmaceuticals Corporation, East Hanover, NJ
Document TitleYearSource
Efficacy and tolerability of two single-day regimens of triclabendazole for fascioliasis in Peruvian children. 2015Revista da Sociedade Brasileira de Medicina Tropical